We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Divi’s Laboratories has been warned by the FDA for failing to meet current good manufacturing practice requirements, adding to the Indian drug manufacturer’s compliance woes. Read More
Glatt Air Techniques did not properly clean manufacturing equipment and failed to quarantine drug products before release, according to the FDA. Read More